These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24886378)

  • 1. Processes to manage analyses and publications in a phase III multicenter randomized clinical trial.
    Snow KK; Bell MC; Stoddard AM; Curto TM; Wright EC; Dienstag JL
    Trials; 2014 May; 15():159. PubMed ID: 24886378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to the International Committee of Medical Journal Editors' (ICMJE) prospective registration policy and implications for outcome integrity: a cross-sectional analysis of trials published in high-impact specialty society journals.
    Gopal AD; Wallach JD; Aminawung JA; Gonsalves G; Dal-Ré R; Miller JE; Ross JS
    Trials; 2018 Aug; 19(1):448. PubMed ID: 30134950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance with trial registration in five core journals of clinical geriatrics: a survey of original publications on randomised controlled trials from 2008 to 2012.
    Mann E; Nguyen N; Fleischer S; Meyer G
    Age Ageing; 2014 Nov; 43(6):872-6. PubMed ID: 24982096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptance and rejection of manuscripts for publication in the American Journal of Pharmaceutical Education.
    DiPiro JT
    Am J Pharm Educ; 2013 May; 77(4):66. PubMed ID: 23716734
    [No Abstract]   [Full Text] [Related]  

  • 5. [Peginterferon-alfa-2b or -alfa-2a and ribavirin combined treatment in hepatitis C infection].
    Szalay F
    Orv Hetil; 2010 Feb; 151(7):271-3. PubMed ID: 20133247
    [No Abstract]   [Full Text] [Related]  

  • 6. [ANRS HC 02 RIBAVIC: from multicenter trial to daily practice. Conclusions].
    Pol S
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S118-9. PubMed ID: 19375040
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing the Quality of Abstracts in Randomized Controlled Trials Published in High Impact Cardiovascular Journals.
    Khan MS; Shaikh A; Ochani RK; Akhtar T; Fatima K; Khan SU; Mookadam F; Murad MH; Figueredo VM; Doukky R; Krasuski RA
    Circ Cardiovasc Qual Outcomes; 2019 May; 12(5):e005260. PubMed ID: 31030545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of study outcome on submission and acceptance metrics for peer reviewed medical journals: six year retrospective review of all completed GlaxoSmithKline human drug research studies.
    Evoniuk G; Mansi B; DeCastro B; Sykes J
    BMJ; 2017 Apr; 357():j1726. PubMed ID: 28432051
    [No Abstract]   [Full Text] [Related]  

  • 9. Pegylated interferon-α2a and ribavirin versus pegylated interferon-α2b and ribavirin in chronic hepatitis C : a meta-analysis.
    Flori N; Funakoshi N; Duny Y; Valats JC; Bismuth M; Christophorou D; Daurès JP; Blanc P
    Drugs; 2013 Mar; 73(3):263-77. PubMed ID: 23436591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second thoughts about secondary analyses.
    Ferenci P
    Dig Liver Dis; 2005 Oct; 37(10):805-7; author reply 808-9. PubMed ID: 16023903
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-sectional study of Pfizer-sponsored clinical trials: assessment of time to publication and publication history.
    Mooney LA; Fay L
    BMJ Open; 2016 Jul; 6(7):e012362. PubMed ID: 27431904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Outcome of treatment with peg-interferon and ribavirin in HIV-HCV co-infected patients: "real life" single center experience].
    Veitsman E; Shahar E; Hassoun G; Lorber M; Kramskay R; Maor C; Pollack S; Baruch Y
    Harefuah; 2012 Dec; 151(12):684-7, 721, 720. PubMed ID: 23330260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].
    Makara M; Horváth G; Gervain J; Pár A; Szalay F; Telegdy L; Tornai I; Ujhelyi E; Hunyady B
    Orv Hetil; 2012 Mar; 153(10):375-94. PubMed ID: 22370225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus interferon: tailored therapy and the impact of adherence.
    Gonzalez SA
    Dig Dis Sci; 2011 Mar; 56(3):631-4. PubMed ID: 21259073
    [No Abstract]   [Full Text] [Related]  

  • 15. [ANRS HC 02 RIBAVIC: from multicenter trial to daily practice].
    Pol S
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S91-3. PubMed ID: 19375041
    [No Abstract]   [Full Text] [Related]  

  • 16. Noncompliance with guidelines for the treatment of hepatitis C is frequent in daily practice.
    Niederau C; Mauss S; Böker K; Lutz T; Heyne R; Moog G; John C; Witthöft T; Alshuth U; Hüppe D
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):65-73. PubMed ID: 23751351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect and safety of the treatment of recurrent hepatitis C infection after orthotopic liver transplantation with pegylated interferon α2b and ribavirin.
    Perrakis A; Yedibela S; Schuhmann S; Croner R; Schellerer V; Demir R; Hohenberger W; Müller V
    Transplant Proc; 2011 Dec; 43(10):3824-8. PubMed ID: 22172854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of hepatocellular carcinoma 13 years after successful antiviral treatment for HCV infection.
    Puoti C; Lanzetta G; Scotti E
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):408-9. PubMed ID: 27689211
    [No Abstract]   [Full Text] [Related]  

  • 19. The combination of MK-5172, peginterferon, and ribavirin is effective in treatment-naive patients with hepatitis C virus genotype 1 infection without cirrhosis.
    Manns MP; Vierling JM; Bacon BR; Bruno S; Shibolet O; Baruch Y; Marcellin P; Caro L; Howe AY; Fandozzi C; Gress J; Gilbert CL; Shaw PM; Cooreman MP; Robertson MN; Hwang P; Dutko FJ; Wahl J; Mobashery N
    Gastroenterology; 2014 Aug; 147(2):366-76.e6. PubMed ID: 24727022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegylated interferon-α2a versus pegylated interferon-α2b in hepatitis C: reappraisal of effectiveness on the basis of trial sequential analysis.
    Messori A; Fadda V; Maratea D; Trippoli S; Marinai C
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):246-8. PubMed ID: 24366456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.